Autonomix Medical (NASDAQ:AMIX) Announces Earnings Results

Autonomix Medical (NASDAQ:AMIX) released its quarterly earnings data on Wednesday. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.10, FiscalAI reports.

Autonomix Medical Trading Down 1.7%

Autonomix Medical stock opened at $0.38 on Friday. The company has a market capitalization of $2.63 million, a price-to-earnings ratio of -0.11 and a beta of -2.58. Autonomix Medical has a 12 month low of $0.34 and a 12 month high of $3.09. The stock’s 50 day moving average is $0.53 and its 200-day moving average is $0.90.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Autonomix Medical in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $5.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.